Moderna MRNA revenue for Q3 2021

The Moderna sign is visible outside their headquarters in Cambridge, Massachusetts on March 11, 2021.

Boston Globe | Getty Images

Moderna shares tumbled 8% on Thursday after the company cut its annual Covid-19 vaccine sales forecast to $ 15-18 billion from $ 20 billion.

This is an evolving story. Please stay tuned.

Source link

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button